873 related items for PubMed ID: 10653049
21. Efficacy and safety of salmeterol/fluticasone propionate delivered via a hydrofluoroalkane metered dose inhaler in Chinese patients with moderate asthma poorly controlled with inhaled corticosteroids.
You-Ning L, Humphries M, Du X, Wang L, Jiang J.
Int J Clin Pract; 2005 Jul; 59(7):754-9. PubMed ID: 15963199
[Abstract] [Full Text] [Related]
22. Evaluation of different inhaled combination therapies (EDICT): a randomised, double-blind comparison of Seretide (50/250 microg bd Diskus vs. formoterol (12 microg bd) and budesonide (800 microg bd) given concurrently (both via Turbuhaler) in patients with moderate-to-severe asthma.
Ringdal N, Chuchalin A, Chovan L, Tudoric N, Maggi E, Whitehead PJ, EDICT Investigators.
Respir Med; 2002 Nov; 96(11):851-61. PubMed ID: 12418582
[Abstract] [Full Text] [Related]
23. A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD.
Donohue JF, Kalberg C, Emmett A, Merchant K, Knobil K.
Treat Respir Med; 2004 Nov; 3(3):173-81. PubMed ID: 15219176
[Abstract] [Full Text] [Related]
24. Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.
Vogelmeier C, Naya I, Ekelund J.
Clin Drug Investig; 2012 Jul 01; 32(7):439-49. PubMed ID: 22607479
[Abstract] [Full Text] [Related]
25. Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma.
van Noord JA, Schreurs AJ, Mol SJ, Mulder PG.
Thorax; 1999 Mar 01; 54(3):207-12. PubMed ID: 10325895
[Abstract] [Full Text] [Related]
26. Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol/fluticasone propionate in asthma patients aged >or=16 years: post hoc analysis of a randomized, double-blind/open-label extension, parallel-group study.
Aalbers R.
Clin Drug Investig; 2010 Mar 01; 30(7):439-51. PubMed ID: 20528000
[Abstract] [Full Text] [Related]
27. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
Clin Ther; 2007 Jul 01; 29(7):1390-402. PubMed ID: 17825690
[Abstract] [Full Text] [Related]
28. Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.
Lee DK, Jackson CM, Currie GP, Cockburn WJ, Lipworth BJ.
Br J Clin Pharmacol; 2003 Nov 01; 56(5):494-500. PubMed ID: 14651722
[Abstract] [Full Text] [Related]
29. Inhaled salmeterol/fluticasone propionate: a review of its use in asthma.
Reynolds NA, Lyseng-Williamson KA, Wiseman LR.
Drugs; 2005 Nov 01; 65(12):1715-34. PubMed ID: 16060707
[Abstract] [Full Text] [Related]
30. Salmeterol/fluticasone propionate combination therapy 50/250 microg twice daily is more effective than budesonide 800 microg twice daily in treating moderate to severe asthma.
Jenkins C, Woolcock AJ, Saarelainen P, Lundback B, James MH.
Respir Med; 2000 Jul 01; 94(7):715-23. PubMed ID: 10926345
[Abstract] [Full Text] [Related]
31. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
Fowler SJ, Currie GP, Lipworth BJ.
J Allergy Clin Immunol; 2002 Jun 01; 109(6):929-35. PubMed ID: 12063520
[Abstract] [Full Text] [Related]
32. [Influence of changing inhalation device from separate diskus of salmeterol and fluticasone propionate to combination diskus in asthma patients].
Miyagawa T.
Arerugi; 2008 Nov 01; 57(11):1134-44. PubMed ID: 19052508
[Abstract] [Full Text] [Related]
33. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
Frois C, Wu EQ, Ray S, Colice GL.
Clin Ther; 2009 Dec 01; 31(12):2779-803. PubMed ID: 20110019
[Abstract] [Full Text] [Related]
34. Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma.
Condemi JJ, Chervinsky P, Goldstein MF, Ford LB, Berger WE, Ayars GH, Rogenes PR, Edwards L, Pepsin PJ.
J Allergy Clin Immunol; 1997 Oct 01; 100(4):467-74. PubMed ID: 9338539
[Abstract] [Full Text] [Related]
35. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
Clin Ther; 2008 Aug 01; 30(8):1492-504. PubMed ID: 18803991
[Abstract] [Full Text] [Related]
36. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
O'Connor RD, Patrick DL, Parasuraman B, Martin P, Goldman M.
J Asthma; 2010 Mar 01; 47(2):217-23. PubMed ID: 20170333
[Abstract] [Full Text] [Related]
37. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
Daley-Yates PT, Mehta R, Chan RH, Despa SX, Louey MD.
J Aerosol Med Pulm Drug Deliv; 2014 Aug 01; 27(4):279-89. PubMed ID: 24074143
[Abstract] [Full Text] [Related]
38. Steroid-sparing effects of fluticasone propionate 100 microg and salmeterol 50 microg administered twice daily in a single product in patients previously controlled with fluticasone propionate 250 microg administered twice daily.
Busse W, Koenig SM, Oppenheimer J, Sahn SA, Yancey SW, Reilly D, Edwards LD, Dorinsky PM.
J Allergy Clin Immunol; 2003 Jan 01; 111(1):57-65. PubMed ID: 12532097
[Abstract] [Full Text] [Related]
39. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma.
Papi A, Canonica GW, Maestrelli P, Paggiaro P, Olivieri D, Pozzi E, Crimi N, Vignola AM, Morelli P, Nicolini G, Fabbri LM, BEST Study Group.
N Engl J Med; 2007 May 17; 356(20):2040-52. PubMed ID: 17507703
[Abstract] [Full Text] [Related]
40. Efficacy and safety of fluticasone propionate 44 microg/salmeterol 21 microg administered in a hydrofluoroalkane metered-dose inhaler as an initial asthma maintenance treatment.
Nelson HS, Wolfe JD, Gross G, Greos LS, Baitinger L, Scott C, Dorinsky P.
Ann Allergy Asthma Immunol; 2003 Sep 17; 91(3):263-9. PubMed ID: 14533658
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
